$QLGN
Qualigen Therapeutics, Inc. Stock $qlgn

$qlgn Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000149315222022898 Filed on August 15, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$1.441M	$1.431M	$722.0K
YoY Change	24.76%	27.96%	-62.0%
Cost Of Revenue	$91.00K	$72.00K	$828.9K
YoY Change	-90.84%	157.14%	-30.93%
Gross Profit	$1.350M	$1.359M	-$106.8K
YoY Change	733.63%	24.64%	-115.26%
Gross Profit Margin	93.69%	94.97%	-14.79%
Selling, General & Admin	$2.858M	$2.966M	$3.037M
YoY Change	-0.99%	-3.94%	0.9%
% of Gross Profit	211.69%	218.32%
Research & Development	$1.688M	$1.506M	$1.865M
YoY Change	-18.97%	-66.59%	-46.72%
% of Gross Profit	125.04%	110.87%
Depreciation & Amortization	$24.00K	$24.00K	$29.75K
YoY Change	-16.26%	41.18%	-0.83%
% of Gross Profit	1.78%	1.77%
Operating Expenses	$5.824M	$5.572M	$4.902M
YoY Change	17.19%	-34.55%	-24.7%
Operating Profit	-$4.383M	-$4.141M	-$5.009M
YoY Change	-8.84%	-44.0%	-13.79%
Interest Expense	$4.630K	$4.820K	$6.310K
YoY Change	-31.91%	-62.11%	-99.71%
% of Operating Profit
Other Income/Expense, Net	$327.1K	$19.25K	$160.0K
YoY Change	-81.47%	-99.04%
Pretax Income	-$4.056M	-$4.122M	-$4.319M
YoY Change	33.57%	-23.63%	17.69%
Income Tax		$5.438K	$740.00
% Of Pretax Income
Net Earnings	-$3.825M	-$4.123M	-$4.320M
YoY Change	25.93%	-23.61%	-17.6%
Net Earnings / Revenue	-265.44%	-288.24%	-598.28%
Basic Earnings Per Share	-$0.10	-$0.11	-$1.22
Diluted Earnings Per Share	-$1.028M	-$112.5K	-$122.4K
COMMON SHARES
Basic Shares Outstanding	38.80M shares	36.68M shares	3.529M shares
Diluted Shares Outstanding	3.944M shares	3.668M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.618M	$9.746M	$13.61M
YoY Change	-46.28%	-36.02%	-37.99%
Cash & Equivalents	$6.624M	$9.752M	$13.61M
Short-Term Investments
Other Short-Term Assets	$1.692M	$1.928M	$1.098M
YoY Change	5.68%	-5.19%	-10.01%
Inventory	$1.482M	$1.310M	$1.401M
Prepaid Expenses
Receivables	$603.3K	$719.9K	$594.3K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$10.40M	$13.70M	$16.70M
YoY Change	-33.93%	-28.27%	-32.97%
LONG-TERM ASSETS
Property, Plant & Equipment	$311.5K	$329.6K	$1.822M
YoY Change	-34.52%	-43.18%	198.61%
Goodwill	$4.896M	$4.896M
YoY Change
Intangibles	$5.852M	$5.858M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$18.33K	$18.33K	$18.33K
YoY Change	0.02%	0.02%	-8.35%
Total Long-Term Assets	$12.56M	$12.64M	$2.005M
YoY Change	1770.44%	1516.03%	144.47%
TOTAL ASSETS
Total Short-Term Assets	$10.40M	$13.70M	$16.70M
Total Long-Term Assets	$12.56M	$12.64M	$2.005M
Total Assets	$22.96M	$26.35M	$18.71M
YoY Change	39.95%	32.48%	-27.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$596.0K	$918.3K	$997.4K
YoY Change	-34.41%	17.06%	103.55%
Accrued Expenses	$1.471M	$1.415M	$1.423M
YoY Change	-27.32%	-34.03%	-31.28%
Deferred Revenue
YoY Change
Short-Term Debt	$941.3K	$939.9K	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.881M	$5.646M	$3.626M
YoY Change	-10.06%	-23.88%	-60.59%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.426M	$1.497M	$1.566M
YoY Change	984.48%	612.0%	421.97%
Total Long-Term Liabilities	$1.426M	$1.497M	$1.566M
YoY Change	984.48%	612.0%	421.97%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.881M	$5.646M	$3.626M
Total Long-Term Liabilities	$1.426M	$1.497M	$1.566M
Total Liabilities	$7.043M	$7.879M	$5.192M
YoY Change	26.71%	3.3%	-45.41%
SHAREHOLDERS EQUITY
Retained Earnings	-$97.00M	-$93.19M
YoY Change
Common Stock	$42.11K	$38.80K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$12.15M	$14.47M	$13.52M
YoY Change
Total Liabilities & Shareholders Equity	$22.96M	$26.35M	$18.71M
YoY Change	39.95%	32.48%	-27.32%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$3.825M	-$4.123M	-$4.320M
YoY Change	25.93%	-23.61%	-17.6%
Depreciation, Depletion And Amortization	$24.00K	$24.00K	$29.75K
YoY Change	-16.26%	41.18%	-0.83%
Cash From Operating Activities	-$3.182M	-$3.946M	-$3.882M
YoY Change	4.94%	-41.15%	86.62%
INVESTING ACTIVITIES
Capital Expenditures	-$11.26K	-$13.85K	-$49.63K
YoY Change	16.44%	-69.01%	-29.1%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$135.4K
YoY Change
Cash From Investing Activities	-$11.26K	$121.5K	-$49.63K
YoY Change	16.44%	-371.87%	-29.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.310K	0.000	3.860K
YoY Change	-97.44%	-100.0%	-96.78%
NET CHANGE
Cash From Operating Activities	-3.182M	-3.946M	-3.882M
Cash From Investing Activities	-11.26K	121.5K	-49.63K
Cash From Financing Activities	3.310K	0.000	3.860K
Net Change In Cash	-3.190M	-3.825M	-3.927M
YoY Change	9.52%	-43.04%	93.47%
FREE CASH FLOW
Cash From Operating Activities	-$3.182M	-$3.946M	-$3.882M
Capital Expenditures	-$11.26K	-$13.85K	-$49.63K
Free Cash Flow	-$3.171M	-$3.932M	-$3.832M
YoY Change	4.9%	-40.96%	90.65%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001460702
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents		usd
CY2021Q4	us-gaap	Goodwill Goodwill		usd
CY2021Q4	QLGN	Research And Development Grant Liability ResearchAndDevelopmentGrantLiability		usd
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings		usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities		usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax		usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest		usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax		usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest		usd
CY2021Q1	QLGN	Stock Issued During Period Value Warrants Exercised On Net Basis StockIssuedDuringPeriodValueWarrantsExercisedOnNetBasis		usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	QLGN	Issuance Of Common Stock For Professional Services IssuanceOfCommonStockForProfessionalServices		usd
	QLGN	Transfers Of Inventory From Equipment Held For Lease TransfersOfInventoryFromEquipmentHeldForLease		usd
	QLGN	Fair Value Of Shares Issued For Cashless Warrant Exercises FairValueOfSharesIssuedForCashlessWarrantExercises		usd
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired		usd
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1		usd
	QLGN	Fair Value Of Warrants Repriced Due To Acquisition FairValueOfWarrantsRepricedDueToAcquisition		usd
	QLGN	Fair Value Of Prefunded Warrant Issued In Exchange For Nanosynex Stock FairValueOfPrefundedWarrantIssuedInExchangeForNanosynexStock		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1		usd
CY2021Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents		usd
CY2021Q4	us-gaap	Goodwill Goodwill		usd
CY2022Q2	QLGN	Dilutive Potential Shares Issuable From Stock Options And Warrants DilutivePotentialSharesIssuableFromStockOptionsAndWarrants		shares
CY2021Q2	QLGN	Dilutive Potential Shares Issuable From Stock Options And Warrants DilutivePotentialSharesIssuableFromStockOptionsAndWarrants		shares
	QLGN	Dilutive Potential Shares Issuable From Stock Options And Warrants DilutivePotentialSharesIssuableFromStockOptionsAndWarrants		shares
	QLGN	Dilutive Potential Shares Issuable From Stock Options And Warrants DilutivePotentialSharesIssuableFromStockOptionsAndWarrants		shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	Qualigen Therapeutics, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity File Number EntityFileNumber	001-37428
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-3474527
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2042 Corte Del Nogal
	dei	Entity Address City Or Town EntityAddressCityOrTown	Carlsbad
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92011
	dei	City Area Code CityAreaCode	(760)
	dei	Local Phone Number LocalPhoneNumber	918-9165
	dei	Security12b Title Security12bTitle	Common Stock, par value $.001 per share
	dei	Trading Symbol TradingSymbol	QLGN
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	38795541	shares
CY2022Q2	us-gaap	Cash Cash	9746257	usd
CY2021Q4	us-gaap	Cash Cash	17538272	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	719883	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	822351	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	1310213	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	1055878	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1928383	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1379896	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	13704736	usd
CY2022Q2	us-gaap	Deferred Income Current DeferredIncomeCurrent	109833	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	20796397	usd
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	5719	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1535764	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1645568	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	329630	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	204216	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5858446	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	171190	usd
CY2022Q2	us-gaap	Goodwill Goodwill	4896223	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	18333	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	18334	usd
CY2022Q2	us-gaap	Assets Assets	26348851	usd
CY2021Q4	us-gaap	Assets Assets	22835705	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	918327	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	886224	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1414535	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1793901	usd
CY2022Q2	QLGN	Research And Development Grant Liability ResearchAndDevelopmentGrantLiability	1098733	usd
CY2021Q4	us-gaap	Deferred Income Current DeferredIncomeCurrent	135063	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	177439	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	134091	usd
CY2022Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	939919	usd
CY2022Q2	us-gaap	Hedging Liabilities Current HedgingLiabilitiesCurrent	987300	usd
CY2021Q4	us-gaap	Hedging Liabilities Current HedgingLiabilitiesCurrent	1686200	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5646086	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4635479	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1425808	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1542564	usd
CY2022Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	70814	usd
CY2021Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	92928	usd
CY2022Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	736000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	7878708	usd
CY2021Q4	us-gaap	Liabilities Liabilities	6270971	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	225000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	225000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38795541	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38795541	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35290178	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35290178	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	38795	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	35290	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	107557744	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	101274073	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	65540	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-93187820	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-84744629	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	14474259	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16564734	usd
CY2022Q2	us-gaap	Minority Interest MinorityInterest	3995884	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18470143	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16564734	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26348851	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22835705	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1430534	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1117935	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2152563	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3017430	usd
CY2022Q2	QLGN	Cost Of Product Sales CostOfProductSales	1099677	usd
CY2021Q2	QLGN	Cost Of Product Sales CostOfProductSales	916624	usd
	QLGN	Cost Of Product Sales CostOfProductSales	1928524	usd
	QLGN	Cost Of Product Sales CostOfProductSales	2119103	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2660857	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2952100	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5559608	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5826038	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1506227	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4508466	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3370972	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8007840	usd
CY2022Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	305103	usd
CY2021Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	135543	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	443426	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	272129	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	5571864	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	8512733	usd
	us-gaap	Operating Expenses OperatingExpenses	11302530	usd
	us-gaap	Operating Expenses OperatingExpenses	16225110	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4141330	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-7394798	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9149967	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13207680	usd
CY2022Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	14800	usd
CY2021Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1982256	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	698042	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2535064	usd
CY2022Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	4824	usd
CY2021Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	12718	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	11132	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	30061	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-376	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2352	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-341	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2894	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	19248	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1997326	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	708833	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2568019	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4122082	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5397472	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8441134	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10639661	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5438	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	605	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6173	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1135	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-4127520	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-5398077	usd
	us-gaap	Profit Loss ProfitLoss	-8447307	usd
	us-gaap	Profit Loss ProfitLoss	-10640796	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-4116	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-4116	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-4123404	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-5398077	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8443191	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10640796	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36680156	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28850451	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35990933	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28510014	shares
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-4127520	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-5398077	usd
	us-gaap	Profit Loss ProfitLoss	-8447307	usd
	us-gaap	Profit Loss ProfitLoss	-10640796	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	65540	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	65540	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-4061980	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-5398077	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-8381767	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-10640796	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-4116	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-4116	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4057864	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5398077	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8377651	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10640796	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16564734	usd
CY2022Q1	QLGN	Stock Issued During Period Value Warrants Exercised One StockIssuedDuringPeriodValueWarrantsExercisedOne	4716	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	1267166	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-4319787	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13516829	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1844500	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1746816	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	65540	usd
CY2022Q2	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	4000000	usd
CY2022Q2	QLGN	Fair Value Of Warrant Modification For Business Acquisition FairValueOfWarrantModificationForBusinessAcquisition	696	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1423282	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-4127520	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18470143	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18294560	usd
CY2021Q1	QLGN	Stock Issued During Period Value Warrants Exercised One StockIssuedDuringPeriodValueWarrantsExercisedOne	1814673	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	101750	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1262123	usd
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-5242719	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16230387	usd
CY2021Q2	QLGN	Stock Issued During Period Value Warrants Exercised One StockIssuedDuringPeriodValueWarrantsExercisedOne	142582	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1286926	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-5398077	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12261818	usd
	us-gaap	Profit Loss ProfitLoss	-8447307	usd
	us-gaap	Profit Loss ProfitLoss	-10640796	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	66258	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	53736	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	109803	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	109719	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-75295	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3645	usd
	us-gaap	Inventory Write Down InventoryWriteDown	-16405	usd
	us-gaap	Inventory Write Down InventoryWriteDown	40644	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2690447	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2549049	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-698042	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2535064	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-250201	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	154799	usd
	QLGN	Increase Decrease In Inventory And Equipment Held For Leases IncreaseDecreaseInInventoryAndEquipmentHeldForLeases	237930	usd
	QLGN	Increase Decrease In Inventory And Equipment Held For Leases IncreaseDecreaseInInventoryAndEquipmentHeldForLeases	89617	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	548487	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-746787	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	27941	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	283706	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-828229	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	1176970	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-73408	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-122780	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-47345	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-206257	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7827798	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8785057	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	63483	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	107798	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	6893	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	135354	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	71871	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-114691	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3859	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	294319	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	138739	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3859	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	155580	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7752068	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8744168	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-34228	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17538272	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	23976570	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	9751976	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	15232402	usd
	us-gaap	Interest Paid Net InterestPaidNet	1683	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3501	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2200	usd
	QLGN	Issuance Of Common Stock For Professional Services IssuanceOfCommonStockForProfessionalServices	101750	usd
	QLGN	Transfers Of Inventory From Equipment Held For Lease TransfersOfInventoryFromEquipmentHeldForLease	1304	usd
	QLGN	Fair Value Of Shares Issued For Cashless Warrant Exercises FairValueOfSharesIssuedForCashlessWarrantExercises	722970	usd
	QLGN	Fair Value Of Warrant Liabilities On Date Of Exercise FairValueOfWarrantLiabilitiesOnDateOfExercise	858	usd
	QLGN	Fair Value Of Warrant Liabilities On Date Of Exercise FairValueOfWarrantLiabilitiesOnDateOfExercise	1662936	usd
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	5896278	usd
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	2439620	usd
	QLGN	Fair Value Of Warrants Repriced Due To Acquisition FairValueOfWarrantsRepricedDueToAcquisition	696	usd
	QLGN	Fair Value Of Prefunded Warrant Issued In Exchange For Nanosynex Stock FairValueOfPrefundedWarrantIssuedInExchangeForNanosynexStock	-1746816	usd
	us-gaap	Stock Issued1 StockIssued1	1844500	usd
	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	135354	usd
CY2022Q2	us-gaap	Cash Cash	9746257	usd
CY2021Q2	us-gaap	Cash Cash	15232402	usd
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	5719	usd
CY2022Q2	QLGN	Total Cash And Restricted Cash TotalCashAndRestrictedCash	9751976	usd
CY2021Q2	QLGN	Total Cash And Restricted Cash TotalCashAndRestrictedCash	15232402	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_zVZf0jUeOxbk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zBN8eWPqlsYi">Accounting Estimates</span> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management uses estimates and assumptions in preparing its unaudited condensed financial statements in accordance with U.S. GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. The most significant estimates relate to the estimated fair value of in-process research and development, goodwill, warrant liabilities, stock-based compensation, amortization and depreciation, inventory reserves, allowances for doubtful accounts and returns, and warranty costs. Actual results could vary from the estimates that were used.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p>
CY2022Q2	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
CY2021Q2	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2022Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	780684	usd
CY2021Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	958448	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	60801	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	136097	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	719883	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	822351	usd
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	28000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	111000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	58000	usd
CY2022Q2	QLGN	Allowances For Sales Return AllowancesForSalesReturn	10000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	72000	usd
CY2021Q2	QLGN	Allowances For Sales Return AllowancesForSalesReturn	0	usd
	QLGN	Allowances For Sales Return AllowancesForSalesReturn	53000	usd
	QLGN	Allowances For Sales Return AllowancesForSalesReturn	0	usd
	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	the Company with a face value equal to the amount paid by the Company to NanoSynex upon satisfaction of the applicable performance milestone, bearing interest at the rate of 9% per annum on the principal balance from time to time outstanding under the particular promissory note, convertible at the option of the Company into additional shares of NanoSynex in order for the Company to maintain at least a 50.1% controlling ownership interest in NanoSynex, should NanoSynex issue additional shares. The principal of the convertible notes are due and payable upon the sooner to occur of: i) five years from the date of issuance of the particular promissory note
CY2022Q2	us-gaap	Product Warranty Expense ProductWarrantyExpense	22000	usd
CY2021Q2	us-gaap	Product Warranty Expense ProductWarrantyExpense	20000	usd
	us-gaap	Product Warranty Expense ProductWarrantyExpense	41000	usd
	us-gaap	Product Warranty Expense ProductWarrantyExpense	41000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	65540	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	70478	shares
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables	75336	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	120942	usd
CY2022Q2	QLGN	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Research And Development Expense BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentExpense	5700000	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	4588	usd
CY2022Q2	QLGN	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accrued Expenses And Other Payables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpensesAndOtherPayables	-291093	usd
CY2022Q2	QLGN	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Research And Development Grant Liability BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentGrantLiability	-1362264	usd
CY2022Q2	QLGN	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Short Term Debt BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt	-941898	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Deferred Revenue BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue	736000	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Less Noncontrolling Interest BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest	-4000000	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	1439565	usd
CY2022Q2	us-gaap	Goodwill Goodwill	4896223	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	3456658	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	2152563	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	3017430	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-8722302	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-10800317	usd
CY2022Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	63229	usd
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	114760	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1928383	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1379896	usd
CY2022Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	808815	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	823315	usd
CY2022Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	327311	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	188135	usd
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	174087	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	44428	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	1310213	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	1055878	usd
CY2022Q2	us-gaap	Prepaid Insurance PrepaidInsurance	1810413	usd
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1197726	usd
CY2022Q2	QLGN	Prepaid Manufacturing Expenses PrepaidManufacturingExpenses	54741	usd
CY2021Q4	QLGN	Prepaid Manufacturing Expenses PrepaidManufacturingExpenses	67410	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3742289	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3564540	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3412659	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3360324	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	329630	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	204216	usd
CY2022Q2	us-gaap	Depreciation Depreciation	24000	usd
CY2021Q2	us-gaap	Depreciation Depreciation	17000	usd
	us-gaap	Depreciation Depreciation	48000	usd
	us-gaap	Depreciation Depreciation	32000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	4896223	usd
	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P10Y
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	739493	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	726749	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	158446	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	171190	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5858446	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	171190	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	9000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	18000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	15000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	14000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	14000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	14000	usd
CY2022Q2	QLGN	Accrued Compensation AccruedCompensation	26500	usd
CY2021Q4	QLGN	Accrued Compensation AccruedCompensation	17500	usd
CY2022Q2	QLGN	Accrued Franchise Sales And Use Taxes AccruedFranchiseSalesAndUseTaxes	20467	usd
CY2021Q4	QLGN	Accrued Franchise Sales And Use Taxes AccruedFranchiseSalesAndUseTaxes	14090	usd
CY2022Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	4356	usd
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	3620	usd
CY2022Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	101557	usd
CY2021Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	682036	usd
CY2022Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	139551	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	225308	usd
CY2022Q2	QLGN	Accrued Research And Development Current AccruedResearchAndDevelopmentCurrent	299288	usd
CY2021Q4	QLGN	Accrued Research And Development Current AccruedResearchAndDevelopmentCurrent	232712	usd
CY2022Q2	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	13900	usd
CY2021Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	10152	usd
CY2022Q2	us-gaap	Accrued Vacation Current AccruedVacationCurrent	457022	usd
CY2021Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	282910	usd
CY2022Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	101103	usd
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	60281	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	250791	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	265292	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1414535	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1793901	usd
CY2021Q4	QLGN	Fair Value Adjustment Of Warrant FairValueAdjustmentOfWarrant	1686200	usd
	QLGN	Fair Value Of Warrant Liabilities On Date Of Exercise FairValueOfWarrantLiabilitiesOnDateOfExercise	858	usd
	QLGN	Change In Fair Value Of Warrant Liabilities ChangeInFairValueOfWarrantLiabilities	-698042	usd
CY2022Q2	QLGN	Fair Value Adjustment Of Warrant FairValueAdjustmentOfWarrant	987300	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-4123404	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-5398077	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8443191	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10640796	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36680156	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28850451	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35990933	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28510014	shares
CY2022Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	36680156	shares
CY2021Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	28850451	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	35990933	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	28510014	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	18891214	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13917461	shares
CY2021Q4	us-gaap	Area Of Land AreaOfLand	22624	sqft
CY2021Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P61M
CY2021Q4	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	November 1, 2022 to November 30, 2027
CY2021Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P61M
CY2021Q4	us-gaap	Payments For Rent PaymentsForRent	1950710	usd
CY2021Q4	QLGN	Tenant Improvement Allowance TenantImprovementAllowance	339360	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y4M24D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.089	pure
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	277192	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	368341	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	379392	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	390773	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	402497	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	379165	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2197360	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	594113	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1603247	usd
CY2022Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	119000	usd
CY2021Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	86000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	233000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	172000	usd
CY2022Q2	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	96558	usd
CY2022Q1	us-gaap	Indefinite Lived License Agreements IndefiniteLivedLicenseAgreements	150000	usd
CY2022Q1	us-gaap	Other Expenses OtherExpenses	160000	usd
CY2022Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	18891214	shares
CY2022Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	18891214	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2600000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2500000	usd
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	5600000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y1M6D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.02	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.02	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0158	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0167	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0084	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0181	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2022Q2	us-gaap	Share Price SharePrice	1.05
CY2021Q2	us-gaap	Share Price SharePrice	2.12
	us-gaap	Share Based Compensation ShareBasedCompensation	2690447	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2549049	usd
CY2021Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	600000	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.32
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	300000	usd
CY2020Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	2191010	shares
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.07

Files In Submission

Name	View Source	Status
0001493152-22-022898-index-headers.html	Edgar Link	pending
0001493152-22-022898-index.html	Edgar Link	pending
0001493152-22-022898.txt	Edgar Link	pending
0001493152-22-022898-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
qlgn-20220630.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
qlgn-20220630_cal.xml	Edgar Link	unprocessable
qlgn-20220630_def.xml	Edgar Link	unprocessable
qlgn-20220630_lab.xml	Edgar Link	unprocessable
qlgn-20220630_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$QLGN
Qualigen Therapeutics, Inc. Stock $qlgn

2022 Q3 Form 10-Q Financial Statement

#000149315222022898 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QLGN Qualigen Therapeutics, Inc. Stock $qlgn

2022 Q3 Form 10-Q Financial Statement

#000149315222022898 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QLGN
Qualigen Therapeutics, Inc. Stock $qlgn